Trial Profile
PATCAR Pilot Trial: A Phase 4 Study, Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Reteplase (Primary)
- Indications Coronary artery restenosis; Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms PATCAR
- 11 Aug 2023 The protocol has been amended as above-1) Number of arms has been changed from 2 to 4. 2)Promary endpoint has been amended (time frame has been changed from 1 year to 30 days).3) Actual patient number changed from 254 to 390.4) In design parallel and randomized model have been implemented.
- 28 Feb 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 09 Feb 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.